Group One Trading
AQST icon

Group One Trading’s Aquestive Therapeutics AQST Stock Holding History

Group One Trading’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.8K Buy
17,300
+2,000
+13% +$8.12K ﹤0.01% 4997
2025
Q4 		$98.8K Sell
15,300
-30,100
-66% -$188K ﹤0.01% 5022
2025
Q3 		$254K Sell
45,400
-92,000
-67% -$398K ﹤0.01% 4412
2025
Q2 		$455K Buy
137,400
+7,000
+5% +$20.1K ﹤0.01% 3515
2025
Q1 		$378K Buy
130,400
+112,900
+645% +$342K ﹤0.01% 3377
2024
Q4 		$62.3K Sell
17,500
-13,700
-44% -$63.2K ﹤0.01% 4891
2024
Q3 		$155K Buy
31,200
+4,600
+17% +$17.9K ﹤0.01% 3843
2024
Q2 		$69.2K Buy
26,600
+4,700
+21% +$15.7K ﹤0.01% 4267
2024
Q1 		$93.3K Buy
21,900
+21,600
+7,200% +$71.9K ﹤0.01% 4212
2023
Q4 		$606 Sell
300
-10,000
-97% -$17.7K ﹤0.01% 7066
2023
Q3 		$15.8K Buy
10,300
+300
+3% +$516 ﹤0.01% 6067
2023
Q2 		$16.5K Buy
+10,000
New +$18.1K ﹤0.01% 6108
2022
Q3 		– Sell
-4,600
Closed -$3K – 7510
2022
Q2 		$3K Sell
4,600
-5,200
-53% -$6.92K ﹤0.01% 7264
2022
Q1 		$26K Buy
9,800
+2,400
+32% +$7.01K ﹤0.01% 6570
2021
Q4 		$29K Sell
7,400
-26,400
-78% -$132K ﹤0.01% 6737
2021
Q3 		$147K Buy
33,800
+26,900
+390% +$105K ﹤0.01% 5495
2021
Q2 		$27K Sell
6,900
-2,200
-24% -$8.79K ﹤0.01% 7006
2021
Q1 		$47K Buy
9,100
+7,600
+507% +$40.4K ﹤0.01% 6260
2020
Q4 		$8K Sell
1,500
-28,200
-95% -$169K ﹤0.01% 5859
2020
Q3 		$144K Buy
+29,700
New +$194K ﹤0.01% 3907

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's AQST Position: Q3 2025 in Review

Group One Trading sold out of Aquestive Therapeutics (AQST) in Q3 2025, closing a stake of 12,185 shares — an estimated $52.7K sold.

Group One Trading first reported a position in AQST in Q2 2020 and held it in 16 quarters. The position peaked at $297K in Q4 2021. 152 funds tracked by Wall St. Rank hold AQST as of Q3 2025.

  • Group One Trading reported no remaining Aquestive Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 12,185 Aquestive Therapeutics shares in Q3 2025, an estimated $52.7K.
  • Group One Trading first reported a position in Aquestive Therapeutics in Q2 2020 and held it in 16 quarters.
  • Group One Trading's Aquestive Therapeutics position peaked at $297K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.